Testosterone Use Doesn’t Increase Heart Risk, Study Finds

Daniels Tredennick Industrial Accidents and Personal Injury, Pharmaceutical and Mass Torts

A study of 24,000 Medicare patients found that testosterone therapy didn’t increase the risk of heart attack, contrary to several earlier studies, and that it even lowered the risk of heart attack by about 30% in the group of men judged most likely to have one based on other factors. The findings are a boost for proponents of testosterone therapy, …

UPDATE: Testosterone Replacement Therapy (TRT) Litigation

Daniels Tredennick Pharmaceutical and Mass Torts

(1) NPR Discusses Testosterone & Potential Adverse Health Effects NPR recently discussed the popularity of testosterone replacement therapies, and how the The Food and Drug Administration is reassessing the safety of testosterone products. A spokesperson reiterated the agency’s own guidelines: None of the products approved by the FDA should be prescribed unless low testosterone is associated with a medical condition. …

‘Low T’ Drug Cases Involving Abbott’s Androgel Could Be Next MDL, Mass Tort

Daniels Tredennick Pharmaceutical and Mass Torts

  Several products liability attorneys say that the recent appearance of lawsuits nationwide against the manufacturers of testosterone therapy drugs indicates the potential for multidistrict litigation and possibly a new mass tort. Many of the current suits filed in federal courts across the country are against Abbott Laboratories—maker of the topical testosterone therapy drug AndroGel and the anti-seizure medication Depakote.  …